{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:24:49Z","timestamp":1793316289557,"version":"4.5.0"},"reference-count":78,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disease in which disease flares frequently recur at previously affected anatomical sites. This distinctive clinical pattern suggests the presence of residual inflammation and long-lasting local immune memory that persists beyond apparent clinical remission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To synthesize current evidence on the role of tissue-resident memory T (TRM) cells in the pathogenesis, chronicity, and relapse of AD, and to discuss how TRM biology may explain disease recurrence after treatment withdrawal and inform future therapeutic strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Narrative review of experimental, translational, and clinical studies addressing TRM differentiation, persistence, metabolic and epigenetic programming, clonal stability, microenvironmental crosstalk, and treatment-related modulation in AD and related chronic dermatoses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>TRM are long-lived, non-circulating T cells retained in the skin through adhesion molecules, survival cytokines, metabolic adaptation, and stable epigenetic programs. In AD, both CD4+ and CD8+ TRM persist in lesional and clinically resolved skin and remain transcriptionally poised for rapid reactivation. Clinical studies consistently demonstrate disease relapse after discontinuation of biologics and JAK inhibitors, supporting the concept that current therapies suppress inflammatory pathways without eliminating pathogenic tissue memory. Emerging data suggest that selected interventions, including modulation of costimulatory pathways and survival signals, may partially influence immune memory and prolong disease control in subsets of patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>TRM constitute a central cellular substrate of residual disease memory in AD and provide a mechanistic explanation for site-specific relapse and treatment resistance. Therapeutic strategies that selectively modulate pathogenic TRM and their supporting microenvironment, while preserving protective barrier immunity, may be required to achieve durable remission.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1849265","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T04:21:19Z","timestamp":1784521279000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Tissue-resident memory T cells in atopic dermatitis: mechanisms of residual inflammation, relapse, and therapeutic persistence"],"prefix":"10.3389","volume":"17","author":[{"given":"Natalia","family":"Zdanowska","sequence":"first","affiliation":[{"name":"Department of Dermatology, Sexually Transmitted Diseases and Clinical Immunology, University of Warmia and Mazury in Olsztyn","place":["Olsztyn, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Macho\u0144","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Sexually Transmitted Diseases and Clinical Immunology, University of Warmia and Mazury in Olsztyn","place":["Olsztyn, Poland"]},{"name":"Doctoral School of the University of Warmia and Mazury in Olsztyn","place":["Olsztyn, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicja","family":"Fr\u0105czek","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Sexually Transmitted Diseases and Clinical Immunology, University of Warmia and Mazury in Olsztyn","place":["Olsztyn, Poland"]},{"name":"Doctoral School of the University of Warmia and Mazury in Olsztyn","place":["Olsztyn, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Kasprowicz-Furma\u0144czyk","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Sexually Transmitted Diseases and Clinical Immunology, University of Warmia and Mazury in Olsztyn","place":["Olsztyn, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Czerwi\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Sexually Transmitted Diseases and Clinical Immunology, University of Warmia and Mazury in Olsztyn","place":["Olsztyn, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Owczarczyk-Saczonek","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Sexually Transmitted Diseases and Clinical Immunology, University of Warmia and Mazury in Olsztyn","place":["Olsztyn, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaci.2018.10.032","article-title":"Atopic dermatitis endotypes and implications for targeted therapeutics","volume":"143","author":"Czarnowicki","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70029","article-title":"Atopic dermatitis: pathogenesis and therapeutic intervention","volume":"5","author":"Yue","year":"2024","journal-title":"MedComm (2020)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.12.007","article-title":"Tissue-resident memory T cells","volume":"41","author":"Schenkel","year":"2014","journal-title":"Immunity"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3883","article-title":"The emerging role of resident memory T cells in protective immunity and inflammatory disease","volume":"21","author":"Park","year":"2015","journal-title":"Nat Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(25)00003-7","article-title":"Global, regional, and national burden of asthma and atopic dermatitis, 1990-2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021","volume":"13","year":"2025","journal-title":"Lancet Respir Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19580","article-title":"The global burden of atopic dermatitis: lessons from the Global Burden of Disease Study 1990-2017","volume":"184","author":"Laughter","year":"2021","journal-title":"Br J Dermatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18296","article-title":"Increasing severity of atopic dermatitis is associated with a negative impact on work productivity among adults with atopic dermatitis in France, Germany, the U.K. and the U.S.A","volume":"182","author":"Andersen","year":"2020","journal-title":"Br J Dermatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-024-01146-8","article-title":"Real-world clinical, psychosocial, and economic burden of atopic dermatitis: results from the ESSENTIAL AD multicountry study","volume":"14","author":"Gkalpakiotis","year":"2024","journal-title":"Dermatol Ther (Heidelb)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1007\/s00403-025-04176-0","article-title":"Prevalence of sleep disorders in atopic dermatitis: a systematic review and meta-analysis","volume":"317","author":"Zhang","year":"2025","journal-title":"Arch Dermatol Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.5641","article-title":"Assessment of sleep disturbances and exhaustion in mothers of children with atopic dermatitis","volume":"155","author":"Ramirez","year":"2019","journal-title":"JAMA Dermatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S404350","article-title":"Implications of atopic dermatitis on the quality of life of 6-11 years old children and caregivers (PEDI-BURDEN)","volume":"16","author":"Neri","year":"2023","journal-title":"J Asthma Allergy"},{"key":"B12","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.jaad.2018.03.017","article-title":"Association of atopic dermatitis with depression, anxiety, and suicidal ideation in children and adults: A systematic review and meta-analysis","volume":"79","author":"R\u00f8nnstad","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.jaip.2019.08.030","article-title":"Atopic eczema in adulthood and risk of depression and anxiety: A population-based cohort study","volume":"8","author":"Schonmann","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2019.3617","article-title":"Efficacy and safety of multiple dupilumab dose regimens after initial successful treatment in patients with atopic dermatitis: A randomized clinical trial","volume":"156","author":"Worm","year":"2020","journal-title":"JAMA Dermatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/exd.15175","article-title":"Possibility of maintaining remission with topical therapy alone after withdrawal of dupilumab in Japanese patients with atopic dermatitis and their characteristics in the real world","volume":"33","author":"Watanabe","year":"2024","journal-title":"Exp Dermatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v102.295","article-title":"Long-term remission of atopic dermatitis after discontinuation of dupilumab","volume":"102","author":"Miyamoto","year":"2022","journal-title":"Acta Derm Venereol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.05.075","article-title":"Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate-to-severe atopic dermatitis: results from the JAK1 Atopic Dermatitis Efficacy and Safety (JADE) REGIMEN phase 3 trial","volume":"86","author":"Blauvelt","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19391","article-title":"Upadacitinib treatment withdrawal and retreatment in patients with moderate-to-severe atopic dermatitis: Results from a phase 2b, randomized, controlled trial","volume":"37","author":"Guttman-Yassky","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1089\/derm.2024.0014","article-title":"Efficacy, safety, and early relapse after cessation of upadacitinib versus dupilumab in adolescents with moderate-to-severe atopic dermatitis: A real-world study in China","volume":"35","author":"Zhu","year":"2024","journal-title":"Dermatitis"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.15688","article-title":"Atopic dermatitis relapse after treatment discontinuation and predictive factors for relapse: JAK1 inhibitors versus dupilumab","volume":"23","author":"Wu","year":"2025","journal-title":"J Dtsch Dermatol Ges"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-023-00806-3","article-title":"Tralokinumab efficacy over 1 year in adults with moderate-to-severe atopic dermatitis: pooled data from two phase III trials","volume":"24","author":"Simpson","year":"2023","journal-title":"Am J Clin Dermatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljad022","article-title":"Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: 52-week results of two randomized double-blinded placebo-controlled phase III trials","volume":"188","author":"Blauvelt","year":"2023","journal-title":"Br J Dermatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.20877","article-title":"Improvement and maintenance of clinical outcome assessments in atopic dermatitis with amlitelimab","volume":"39","author":"Blauvelt","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-025-01609-6","article-title":"A post hoc analysis of atopic dermatitis of the head and neck and other body regions from the amlitelimab STREAM-AD phase 2b study","volume":"16","author":"Reich","year":"2025","journal-title":"Dermatol Ther (Heidelb)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2024.10.031","article-title":"Phase 2b randomized clinical trial of amlitelimab, an anti-OX40 ligand antibody, in patients with moderate-to-severe atopic dermatitis","volume":"155","author":"Weidinger","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606490","article-title":"Anti-interleukin-31 receptor A antibody for atopic dermatitis","volume":"376","author":"Ruzicka","year":"2017","journal-title":"N Engl J Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.20873","article-title":"Nemolizumab plus topical agents in patients with atopic dermatitis (AD) and moderate-to-severe pruritus provide improvement in pruritus and signs of AD for up to 68 weeks: results from two phase III, long-term studies","volume":"186","author":"Kabashima","year":"2022","journal-title":"Br J Dermatol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"269rv1","DOI":"10.1126\/scitranslmed.3010641","article-title":"Resident memory T cells in human health and disease","volume":"7","author":"Clark","year":"2015","journal-title":"Sci Transl Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1097\/aci.0000000000000763","article-title":"Role of tissue-resident memory T cells in the pathophysiology of allergic contact dermatitis","volume":"21","author":"Lefevre","year":"2021","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2023.109805","article-title":"Neutrophil recruitment by CD4 tissue-resident memory T cells induces chronic recurrent inflammation in atopic dermatitis","volume":"256","author":"Zheng","year":"2023","journal-title":"Clin Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1415914","article-title":"The role of circulating T cells with a tissue resident phenotype (ex-TRM) in health and disease","volume":"15","author":"Rodger","year":"2024","journal-title":"Front Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.618897","article-title":"Pathophysiology of skin resident memory T cells","volume":"11","author":"Tokura","year":"2021","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aam6346","article-title":"Resident memory T cells in the skin mediate durable immunity to melanoma","volume":"2","author":"Malik","year":"2017","journal-title":"Sci Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2019.06.002","article-title":"Significance of IL-17A-producing CD8+CD103+ skin resident memory T cells in psoriasis lesion and their possible relationship to clinical course","volume":"95","author":"Kurihara","year":"2019","journal-title":"J Dermatol Sci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.17748","article-title":"CD8 resident memory T cells with interleukin 17A-producing potential are accumulated in disease-na\u00efve nonlesional sites of psoriasis possibly in correlation with disease duration","volume":"181","author":"Vo","year":"2019","journal-title":"Br J Dermatol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13843","article-title":"The role and therapeutic strategies for tissue-resident memory T cells, central memory T cells, and effector memory T cells in psoriasis","volume":"173","author":"Deng","year":"2024","journal-title":"Immunology"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102868","article-title":"Emerging role of Tissue Resident Memory T cells in vitiligo: From pathogenesis to therapeutics","volume":"20","author":"Shah","year":"2021","journal-title":"Autoimmun Rev"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.jaci.2018.03.018","article-title":"Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension study","volume":"142","author":"Kabashima","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.08.038","article-title":"Vitiligo skin is imprinted with resident memory CD8 T cells expressing CXCR3","volume":"138","author":"Boniface","year":"2018","journal-title":"J Invest Dermatol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70182","article-title":"Alopecia areata: pathogenesis, diagnosis, and therapies","volume":"6","author":"Ma","year":"2025","journal-title":"MedComm (2020)"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1822561","article-title":"Exercise and tissue-resident memory T cells: from circulating numbers to spatial immune remodeling","volume":"17","author":"Xie","year":"2026","journal-title":"Front Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1119383","article-title":"Tissue-resident memory T cells in gastrointestinal tumors: turning immune desert into immune oasis","volume":"14","author":"Liang","year":"2023","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.11.015","article-title":"Generalized bullous fixed drug eruption is distinct from Stevens-Johnson syndrome\/toxic epidermal necrolysis by immunohistopathological features","volume":"70","author":"Cho","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000003499","article-title":"Tissue-resident memory T cells and their function in skin diseases","volume":"138","author":"Chen","year":"2025","journal-title":"Chin Med J (Engl)"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222312933","article-title":"Malignant and benign T cells constituting cutaneous T-cell lymphoma","volume":"22","author":"Nakai","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B46","doi-asserted-by":"publisher","first-page":"117ra7","DOI":"10.1126\/scitranslmed.3003008","article-title":"Skin effector memory T cells do not recirculate and provide immune protection in alemtuzumab-treated CTCL patients","volume":"4","author":"Clark","year":"2012","journal-title":"Sci Transl Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13687","article-title":"A case of CD8(+) primary cutaneous peripheral T-cell lymphoma arising from tissue-resident memory T cells in the skin","volume":"173","author":"Miyagawa","year":"2015","journal-title":"Br J Dermatol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.01.042","article-title":"Single-cell transcriptome analysis of human skin identifies novel fibroblast subpopulation and enrichment of immune subsets in atopic dermatitis","volume":"145","author":"He","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1111\/all.13223","article-title":"Nonlesional atopic dermatitis skin shares similar T-cell clones with lesional tissues","volume":"72","author":"Brunner","year":"2017","journal-title":"Allergy"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2023.11.017","article-title":"Resident memory T cells in nonlesional skin and healed lesions of patients with chronic inflammatory diseases: Appearances can be deceptive","volume":"153","author":"Migayron","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22169004","article-title":"Tissue-resident memory T cells in skin diseases: A systematic review","volume":"22","author":"Emmanuel","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B52","doi-asserted-by":"publisher","first-page":"9233","DOI":"10.3390\/ijms26189233","article-title":"Advances in psoriasis research: decoding immune circuits and developing novel therapies","volume":"26","author":"Wang","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3390\/cells10020409","article-title":"Tissue\u2013resident memory T cells in chronic inflammation\u2014local cells with systemic effects","volume":"10","author":"Samat","year":"2021","journal-title":"Cells"},{"key":"B54","volume-title":"Immunologia","author":"Jak\u00f3bisiak","year":"2017"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1111\/cod.13959","article-title":"Dysregulation of the epithelial barrier by environmental and other exogenous factors","volume":"85","author":"Mitamura","year":"2021","journal-title":"Contact Dermatitis"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3962","article-title":"Hair follicle-derived IL-7 and IL-15 mediate skin-resident memory T cell homeostasis and lymphoma","volume":"21","author":"Adachi","year":"2015","journal-title":"Nat Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jdermsci.2019.08.006","article-title":"Interleukin-33 in atopic dermatitis","volume":"96","author":"Imai","year":"2019","journal-title":"J Dermatol Sci"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/j.jaci.2020.02.026","article-title":"ILC2 activation by keratinocyte-derived IL-25 drives IL-13 production at sites of allergic skin inflammation","volume":"145","author":"Leyva-Castillo","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2005.02875.x","article-title":"Interleukin-4 and interleukin-13 enhance CCL26 production in a human keratinocyte cell line, HaCaT cells","volume":"141","author":"Kagami","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxq027","article-title":"Activation of human eosinophils and epidermal keratinocytes by Th2 cytokine IL-31: implication for the immunopathogenesis of atopic dermatitis","volume":"22","author":"Cheung","year":"2010","journal-title":"Int Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.jaci.2010.09.002","article-title":"Staphylococcus aureus membrane and diacylated lipopeptide induce thymic stromal lymphopoietin in keratinocytes through the Toll-like receptor 2-Toll-like receptor 6 pathway","volume":"126","author":"Vu","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nature12655","article-title":"Staphylococcus \u03b4-toxin induces allergic skin disease by activating mast cells","volume":"503","author":"Nakamura","year":"2013","journal-title":"Nature"},{"key":"B63","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.immuni.2019.06.009","article-title":"Neuropeptide CGRP limits group 2 innate lymphoid cell responses and constrains type 2 inflammation","volume":"51","author":"Nagashima","year":"2019","journal-title":"Immunity"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/nature23469","article-title":"Neuronal regulation of type 2 innate lymphoid cells via neuromedin U","volume":"549","author":"Cardoso","year":"2017","journal-title":"Nature"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2009.358","article-title":"The histamine H4 receptor mediates inflammation and pruritus in Th2-dependent dermal inflammation","volume":"130","author":"Cowden","year":"2010","journal-title":"J Invest Dermatol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abl9165","article-title":"Classification of human chronic inflammatory skin disease based on single-cell immune profiling","volume":"7","author":"Liu","year":"2022","journal-title":"Sci Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2022.02.008","article-title":"Epidermal CD8+CD103+ skin resident memory T cells in psoriasis plaques are reduced in number but remain in the basement membrane zone after topical application of corticosteroid and vitamin D3","volume":"105","author":"Kurihara","year":"2022","journal-title":"J Dermatol Sci"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19148345","article-title":"The effect of the long-term calcipotriol\/betamethasone dipropionate local therapy on tissue resident memory cells markers in psoriatic eruptions","volume":"19","author":"Kasprowicz-Furma\u0144czyk","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"B69","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.jaci.2011.05.042","article-title":"Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response","volume":"128","author":"Tintle","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00338.2022","article-title":"The multifunctional nature of CD103 (\u03b1E\u03b27 integrin) signaling in tissue-resident lymphocytes","volume":"323","author":"Xu","year":"2022","journal-title":"Am J Physiol Cell Physiol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aam7710","article-title":"Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo","volume":"10","author":"Richmond","year":"2018","journal-title":"Sci Transl Med"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3390\/cells10050989","article-title":"TGF-\u03b2: many paths to CD103+ CD8 T cell residency","volume":"10","author":"Qiu","year":"2021","journal-title":"Cells"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/nature21379","article-title":"Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism","volume":"543","author":"Pan","year":"2017","journal-title":"Nature"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1605972","article-title":"Epigenetic control of tissue resident memory T cells","volume":"16","author":"Lan","year":"2025","journal-title":"Front Immunol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.jaci.2025.03.033","article-title":"Subclinical inflammation precedes atopic dermatitis relapses","volume":"156","author":"Al","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1639732","article-title":"Targeting the IL-15\/CD122 signaling pathway: reversing TRM cell-mediated immune memory in vitiligo","volume":"16","author":"Su","year":"2025","journal-title":"Front Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)02037-2","article-title":"An anti-OX40 antibody to treat moderate-to-severe atopic dermatitis: a multicentre, double-blind, placebo-controlled phase 2b study","volume":"401","author":"Guttman-Yassky","year":"2023","journal-title":"Lancet"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.801579","article-title":"Cytokine-mediated crosstalk between keratinocytes and T cells in atopic dermatitis","volume":"13","author":"Humeau","year":"2022","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1849265\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T04:21:21Z","timestamp":1784521281000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1849265\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":78,"alternative-id":["10.3389\/fimmu.2026.1849265"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1849265","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"article-number":"1849265"}}